PDLI Change in Working Capital
Pdl Biopharma Inc · Change in Working Capital
PDLI Change in Working Capital
Latest reported-$223.95Mperiod ending
PDLI TTM Change in Working Capital ($1.80M → -$223.95M)
TTM change in working capital
High-resolution chart · PNG
PDLI change in working capital history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Change in Working Capital (USD) |
|---|---|
| -223,948,000 | |
| -27,294,000 | |
| -29,390,000 | |
| -9,761,000 | |
| -8,626,000 | |
| -4,245,000 | |
| -5,694,000 | |
| -22,023,000 | |
| -36,860,000 | |
| -41,652,000 | |
| -18,836,000 | |
| 20,178,000 | |
| 39,777,000 | |
| 15,341,000 | |
| -3,827,000 | |
| -14,679,000 | |
| -144,000 | |
| 17,538,000 | |
| 32,684,000 | |
| 9,191,000 | |
| -7,644,000 | |
| -3,903,000 | |
| 2,555,000 | |
| 8,635,000 | |
| 6,216,000 | |
| -9,590,000 | |
| -12,514,000 | |
| -12,033,000 | |
| -9,554,000 | |
| -13,929,000 | |
| -2,243,000 | |
| -28,097,000 | |
| -24,711,000 | |
| -25,304,000 | |
| -41,578,000 | |
| -73,181,000 | |
| -17,335,000 | |
| -10,493,000 | |
| 12,267,000 | |
| 70,649,000 | |
| 41,657,000 | |
| 36,151,000 | |
| 4,479,000 | |
| 55,000 | |
| -58,154,000 | |
| -18,525,000 | |
| -24,171,000 | |
| -19,248,000 | |
| 33,765,000 | |
| -9,619,000 | |
| 13,615,000 | |
| -5,655,000 | |
| -25,447,000 | |
| 8,979,000 | |
| 8,129,000 | |
| 31,599,000 | |
| 51,223,000 | |
| 66,323,000 | |
| 42,406,000 | |
| 29,765,000 | |
| 5,945,000 | |
| -8,314,000 | |
| -2,168,000 | |
| 10,062,000 | |
| 13,898,000 | |
| -2,155,000 | |
| 4,725,000 | |
| 2,942,000 | |
| 4,060,000 | |
| 6,564,000 | |
| 7,623,000 | |
| 1,955,000 | |
| 8,279,000 | |
| 4,753,000 | |
| 1,475,000 | |
| -1,040,000 | |
| 462,000 | |
| -6,035,000 | |
| -4,103,000 | |
| 3,902,000 | |
| -6,471,000 | |
| 708,000 | |
| -2,197,000 | |
| -3,700,000 | |
| 2,900,000 | |
| 2,100,000 | |
| -2,900,000 | |
| -1,000,000 | |
| -1,500,000 | |
| 500,000 | |
| 3,600,000 | |
| 1,800,000 | |
| -600,000 | |
| 1,000,000 |